Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials

Anna K Morin, 2014, Off-label use of atypical antipsychotic agents for treatment of insomnia, Mental Health Clin., 4, 65, 10.9740/mhc.n190091 Anderson, 2014, Quetiapine for insomnia: a review of the literature, Am. J. Health Syst. Pharm., 71, 394, 10.2146/ajhp130221 Bandelow, 2010, Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study, Int. J. Neuropsychopharmacol., 13, 305, 10.1017/S1461145709990423 Bauer, 2009, Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study, J. Clin. Psychiatry, 70, 540, 10.4088/JCP.08m04629 Bortnick, 2011, Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study, J. Affect. Disord., 128, 83, 10.1016/j.jad.2010.06.031 Calandre, 2014, Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial, Psychopharmacol. (Berl), 231, 2525, 10.1007/s00213-013-3422-0 Castberg, 2017, Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine, Acta Psychiatr. Scand., 136, 455, 10.1111/acps.12794 Cohrs, 2004, Sleep-promoting properties of quetiapine in healthy subjects, Psychopharmacol. (Berl.), 174, 421, 10.1007/s00213-003-1759-5 Cutler, 2009, Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study, J. Clin. Psychiatry, 70, 526, 10.4088/JCP.08m04592 Debernard, 2019, Quetiapine is not a sleeping pill, Tidsskr Nor Laegeforen, 139 Dubath, 2021, Effect of quetiapine, from low to high dose, on weight and metabolic traits: results from a prospective cohort study, Pharmacopsychiatry, 54, 279, 10.1055/a-1525-2820 Dziurkowska, 2020, Effects of age, drug dose, and sampling time on salivary levels of olanzapine, quetiapine, and their metabolites, J. Clin. Med., 9, 3288, 10.3390/jcm9103288 El-Khalili, 2010, Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study, Int. J. Neuropsychopharmacol., 13, 917, 10.1017/S1461145710000015 Garakani, 2008, A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder, Int. Clin. Psychopharmacol., 23, 269, 10.1097/YIC.0b013e328301a74c Karsten, 2017, Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, crossover, placebo-controlled trial, J. Psychopharmacol., 31, 327, 10.1177/0269881116681399 Katila, 2013, Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder, Am. J. Geriatr. Psychiatry, 21, 769, 10.1016/j.jagp.2013.01.010 Katzman, 2011, Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebo-controlled trial, Int. Clin. Psychopharmacol., 26, 11, 10.1097/YIC.0b013e32833e34d9 Kelly, 2018, The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians, CMAJ Open, 6, E191, 10.9778/cmajo.20170145 Khan, 2011, A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder, Int. Clin. Psychopharmacol., 31, 418, 10.1097/JCP.0b013e318224864d Khurshid, 2018, Comorbid insomnia and psychiatric disorders: an update, Innov. Clin. Neurosci., 15, 28 Lie, 2015, Pharmacological treatment of insomnia, P. T., 40, 759 Liebowitz, 2010, Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial, Depress. Anxiety, 27, 964, 10.1002/da.20740 Lorenz, 2020, Temporal associations of daily changes in sleep and depression core symptoms in patients suffering from major depressive disorder: idiographic time-series analysis, JMIR Ment Health, 7, e17071, 10.2196/17071 Maan, 2022 Maneeton, 2013, Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial, Drug Des. Devel. Ther., 7, 657, 10.2147/DDDT.S45575 Merideth, 2012, Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study, Int. Clin. Psychopharmacol., 27, 40, 10.1097/YIC.0b013e32834d9f49 Mezhebovsky, 2013, Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder, Int. J. Geriatr. Psychiatry, 28, 615, 10.1002/gps.3867 Modesto-Lowe, 2021, Quetiapine for primary insomnia: consider the risks, Cleve. Clin. J. Med., 88, 286, 10.3949/ccjm.88a.20031 Page, 2011, The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, J. Clin. Epidemiol., 134, 178, 10.1016/j.jclinepi.2021.03.001 Riedel, 2007, Quetiapine in the treatment of schizophrenia and related disorders, Neuropsychiatr. Dis. Treat., 3, 219, 10.2147/nedt.2007.3.2.219 Potvin, 2012, Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial, J. Clin. Psychopharmacol., 32, 684, 10.1097/JCP.0b013e318267b8ca Rock, 2016, Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms, J. Psychopharmacol., 30, 273, 10.1177/0269881115626336 Roth, 2007, Insomnia: definition, prevalence, etiology, and consequences, J. Clin. Sleep Med., 3, S7, 10.5664/jcsm.26929 Stahl, 2021 Talih, 2018, Insomnia in hospitalized psychiatric patients: prevalence and associated factors, Neuropsychiatr. Dis. Treat., 14, 969, 10.2147/NDT.S160742 Tassniyom, 2010, Quetiapine for primary insomnia: a double blind, randomized controlled trial, J. Med. Assoc. Thai., 93, 729 Vázquez-Bourgon, 2018, Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis, Psychopharmacology (Berl), 235, 245, 10.1007/s00213-017-4763-x Votaw, 2019, The epidemiology of benzodiazepine misuse: a systematic review, Drug Alcohol Depend, 200, 95, 10.1016/j.drugalcdep.2019.02.033 Wang, 2014, A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder, Neuropsychiatr. Dis. Treat., 10, 201, 10.2147/NDT.S50248 Weisler, 2009, Extended release quetiapine fumarate monotherapy for major depressive disorder: Results of a double-blind, randomized, placebo-controlled study, CNS Spectrums, 14, 299, 10.1017/S1092852900020307 Wine, 2009, Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions, Ann. Pharmacother., 43, 707, 10.1345/aph.1L320 Zhornitsky, 2011, Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials, Int. Clin. Psychopharmacol., 26, 183, 10.1097/YIC.0b013e3283430a0e